Further supporting the role of CD226 in promoting CD8+ T cell pathogenicity in type 1 diabetes, CD226 KO mice showed evidence of reduced TCR avidity of IGRP-reactive CD8+ T cells within the pancreas. Here, CD8A is linked to type 1 diabetes mellitus.